![]() |
|
|
Vol. 17, Issue 4, 1897-1909, April 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



* Department of Medical Oncology, University Medical Center Utrecht, 3584 CG Utrecht, The Netherlands;
Department of Medical Oncology, VU University Medical Center, 1007 MB Amsterdam, The Netherlands
Submitted August 5, 2005;
Revised January 11, 2006;
Accepted January 17, 2006
Monitoring Editor: Ted Salmon
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
In human cells, the chromosome passenger proteins INner CENtromere Protein (INCENP) (Cooke et al., 1987
), Aurora B (Bischoff et al., 1998
), Borealin/Dasra B (Gassmann et al., 2004
; Sampath et al., 2004
), and Survivin (Ambrosini et al., 1997
) exist in a complex termed the chromosomal passenger complex (CPC) (Vagnarelli and Earnshaw, 2004
). Together, they localize to inner centromeres from G2 until the metaphase-to-anaphase transition and then translocate to the spindle midzone during anaphase and eventually localize to the midbody during telophase (Adams et al., 2001
; Vagnarelli and Earnshaw, 2004
). RNA interference (RNAi) knockdown experiments in U2OS and HeLa cells showed that these proteins are mutually dependent on each other for binding to the centromere (Carvalho et al., 2003
; Ditchfield et al., 2003
; Honda et al., 2003
; Lens et al., 2003
; Gassmann et al., 2004
).
For one of the chromosome passenger proteins, Survivin, not only a mitotic regulatory function but also an apoptosis inhibitory function was proposed based on overexpression experiments with mutant Survivin proteins. Overexpression of a Survivin point mutant in which the baculovirus IAP repeat (BIR) domain was disrupted (SurvivinC84A) resulted both in cell division defects and cell death of HeLa cells (Li et al., 1998
, 1999
). In contrast, overexpression of a Survivin mutant that could no longer be phosphorylated by cyclin B/cdc2 (SurvivinT34A) did not result in cell division defects but induced apoptosis, suggesting that Survivin could play a role as an apoptosis inhibitor and as a regulator of cell division (O'Connor et al., 2000
). Importantly, RNAi-mediated knockdown of Survivin in human cells clearly resulted in different mitotic defects, but it did not induce rapid cell death as would be expected from knockdown of an apoptosis inhibitor (Carvalho et al., 2003
; Lens et al., 2003
). These types of experiments not only confirmed the evolutionary conserved roles of Survivin in chromosome alignment and cytokinesis (Fraser et al., 1999
; Li et al., 2000
; Speliotes et al., 2000
) but also revealed that, together with the other passenger proteins, this protein is required to maintain spindle checkpoint activity in particular when cells are challenged with drugs that interfere with the generation of tension between paired sister kinetochores (e.g., paclitaxel and monastrol) (Carvalho et al., 2003
; Ditchfield et al., 2003
; Hauf et al., 2003
; Lens et al., 2003
). Unlike Mad2 and BubR1, Survivin and the other passengers do not directly inhibit the APC/C, yet they enable the cell to communicate lack of tension back to the attached microtubules (Lens and Medema, 2003
). To understand how Survivin is able to coordinate its various functions during mitosis, we complemented Survivin knockdown cells with different point- and deletion mutants of Survivin. Using this approach, we were able to uncouple Survivin's function in the spindle checkpoint from its role during cytokinesis.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Antibodies and Dyes
Mouse anti-MPM-2 and rabbit anti-phospho-CENP-A (Ser7) were from Upstate Biotechnology (Charlottesville, VA), rabbit anti-Aurora B and anti-CENP-A were from Abcam (Cambridge, United Kingdom), mouse anti-Aurora B was from BD Transduction Laboratories (Lexington, KY), rabbit anti-Aurora A was from Cell Signaling Technology (Beverly, MA), and Survivin was from R&D Systems (Minneapolis, MN). Mouse anti-FLAG (M2) and mouse anti-VSV were obtained from Sigma-Aldrich (St. Louis, MO), and sheep anti-BubR1 was a kind gift from Dr. S. Taylor (University of Manchester, Manchester, United Kingdom) (Taylor et al., 2001
). Rabbit anti-Dasra B was a generous gift from Dr. H. Funabiki (Rockefeller University, New York, NY) (Sampath et al., 2004
). Cy5-conjugated donkey anti-mouse was from Jackson ImmunoResearch Laboratories (West Grove, PA). Goat anti-rabbit/Alexa568, goat anti-rabbit/Alexa647, and goat anti-mouse/Alexa568 or Alexa 647 conjugates were from Molecular Probes (Eugene, OR). Peroxidase-conjugated goat anti-rabbit and goat anti-mouse antibodies were from Dako Cytomation Denmark (Glostrup, Denmark). Propidium iodide (PI), thymidine, and paclitaxel were from Sigma-Aldrich.
Cell Culture, Transfection, and Synchronization
U2OS osteosarcoma cells and human embryonic kidney (HEK)293 cells were grown in DMEM supplemented with 6% fetal calf serum and antibiotics. Transfections were performed by the standard calcium phosphate transfection protocol. Where indicated, the cells were synchronized at the G1/S transition by addition of 2.5 mM thymidine directly after washing away the calcium-phosphate precipitate. Cells were maintained in thymidine for 24 h, after which they were released from the block either in the presence or absence of taxol (paclitaxel; 1 µM). Eighteen hours after release, cells were harvested and analyzed by flow cytometry or immunofluorescence. Alternatively, transfected cells were monitored by time-lapse analysis.
Time-Lapse Analysis
U2OS cells were plated on 35-mm glass-bottom culture dishes (Willco-dish, Amsterdam, The Netherlands) and transfected the next day with 1 µg of the pSuper plasmids and 1 µg of the indicated expression plasmids in combination with 0.1 µg of H2B-GFP. Cells were synchronized with thymidine for 24 h and followed by time-lapse microscopy starting 10 h after release from the thymidine block. For life imaging, dishes were transferred to a heated stage (37°C) on a Zeiss Axiovert 200M microscope equipped with a 0.55 numerical aperture (N.A.) condenser and a 40x Achroplan objective (0.60 N.A.). Twelve bits differential interference contrast (DIC) and fluorescence (100-ms exposures) images were captured every 1 to 5 min by using a Photometrics CoolSNAP HQ charged-coupled device camera set at gain 1.0 (Scientific, Tucson, AZ) and appropriate filter cubes (Chroma Technology, Brattleboro, VT) to select specific fluorescence. Images were processed using MetaMorph software (Universal Imaging, Downingtown, PA).
Flow Cytometry
Cells were grown in 10-cm2 dishes and transfected with GFP-spectrin (1 µg), in combination with pSuper or pS-Survivin (10 µg each), and expression plasmids encoding FLAG-tagged versions of the indicated Survivin mutants (1 µg for Survivin1-142, 10 µg for the mutant proteins). Sixty hours after transfection, cells were harvested and fixed in ice-cold 70% ethanol. The fixed cells were washed once with phosphate-buffered saline (PBS) containing 0.05% Tween 20 and then incubated with anti-MPM-2 monoclonal antibody (mAb) diluted in PBS containing 0.05% Tween 20 and 2% bovine serum albumin (BSA) to specifically stain mitotic cells. Finally, cells were stained with a secondary Cy5-conjugated goat-anti-mouse antibody and counterstained with propidium iodide. MPM-2 positivity of the GFP-positive cells was analyzed using flow cytometry (CellQuest; BD Biosciences, San Jose, CA) as described previously (Smits et al., 2000
).
Immunofluorescence
Cells were grown on glass coverslips in 10-cm2 dishes, transfected the next day with GFP-spectrin (1 µg), in combination with pSuper or pS-Survivin (10 µg each) and expression plasmids encoding VSV-tagged versions of the indicated Survivin mutants (1 µg for Survivin1-142, 5-10 µg for the mutant proteins), and synchronized using thymidine. Fourteen hours after thymidine release, coverslips were removed from the culture dish and carefully washed twice with PBS. Cells were then fixed for 5 min in 4% paraformaldehyde plus 0.2% (wt/vol) sucrose at room temperature and subsequently washed with PBS. Cells were then permeabilized for 5 min with 0.5% Triton X-100 (in 20 mM Tris-Cl, pH 7.4, 50 mM NaCl, 300 mM sucrose, and 3 mM MgCl2), blocked in PBS plus 3% BSA, and subsequently incubated with the appropriate primary/secondary antibody combinations diluted in PBS/0.01% Tween 20 and 2% BSA as described previously (Pines, 1997
). Confocal fluorescence images were obtained on a Leica TCS NT (Leica Microsystems, Heidelberg, Germany) confocal system, equipped with an Ar/Kr laser. Images were taken using a 63x 1.3. N.A. objective. Possible bleed-through of the different fluorochromes, which could give rise to false positive colocalization of the signals, was avoided by careful selection of the imaging conditions. Standard filter combination(s) and Kalman averaging was used.
Western Blotting and Immunoprecipitation
Cells were transfected with pBabe-puro (1 µg) in combination with pSuper or pS-Survivin (10 µg each) and expression plasmids encoding FLAG-tagged versions of the indicated Survivin mutants (1 µg for Survivin1-142, 10 µg for the mutant proteins). Twenty-four hours after transfection, puromycin was added, and the viable cells were harvested 36 h later. Cells were lysed in RIPA (1% NP-40, 1% sodium deoxycholate, 0.1% SDS, 0.15 M NaCl, 20 mM Tris-Cl, pH 7.4, and 2 mM EDTA) buffer containing protease inhibitors (Complete; Roche Diagnostics, Mannheim, Germany) on ice, and lysates were cleared by centrifugation. Equal amounts of protein were loaded on SDS-PAGE and subsequently subjected to Western blotting. For immunoprecipitation, cells were lysed in E1A-buffer supplemented with protease inhibitors (Complete) for 30 min at 4°C (Smits et al., 2000
). GFP-tagged proteins were immunoprecipitated with 3 µg of
-GFP polyclonal antibody (pAb) precoupled to protein G-Sepharose (GE Healthcare, Little Chalfont, Buckinghamshire, United Kingdom).
| RESULTS |
|---|
|
|
|---|
|
To test the functionality of these different mutants, U2OS cells were cotransfected with Survivin siRNA, expression plasmids encoding the various proteins and GFP-spectrin as transfection marker. The override of a paclitaxel-induced mitotic arrest was used as measure for an impaired spindle checkpoint. Polyploidy (>4N DNA content) in asynchronous growing cells and tetraploidy (4N DNA content) in synchronized cells (not shown) were taken as a read out for defective cytokinesis (Lens et al., 2003
). When synchronized cells were released from a thymidine block in the presence of paclitaxel, cells lacking Survivin failed to remain arrested in mitosis, resulting in a low mitotic index (Figure 1D, left, and E; Carvalho et al., 2003
; Lens et al., 2003
). Interestingly, only Survivin1-142 and SurvivinT34A were able to restore the spindle checkpoint defect, because cells transfected with these expression plasmids arrested in mitosis upon paclitaxel treatment. However, neither Survivin1-89, nor Survivin89-142 or SurvivinC84A were able to rescue the spindle checkpoint defect (Figure 1D, left, and E). The low mitotic indexes were not because of a G1/S arrest, because all the transfected cell populations accumulated with a 4N DNA content after thymidine release in the presence of paclitaxel (Figure 1D, left). Although ineffective in restoring the spindle checkpoint defect of Survivin-depleted cells, SurvivinC84A and Survivin89-142 were capable of reverting polyploidization induced by Survivin depletion. Whereas SurvivinC84A rescued the cytokinesis failure to a similar extent as the wild-type protein (Survivin1-142) and SurvivinT34A, Survivin89-142 rescued this failure somewhat less efficiently because a fraction of the reconstituted cells accumulated with a 4N DNA content (Figure 1D, right). Survivin1-89, in contrast, was totally incapable of reverting the cytokinesis defect (Figure 1D, right, and F). Thus, whereas Survivin1-142 and SurvivinT34A can functionally complement for endogenous Survivin, the mutant that lacks the C terminus (Survivin1-89) is completely inert. Interestingly, Survivin89-142 and SurvivinC84A can only rescue from polyploidization, but they are incapable of restoring a paclitaxel-induced mitotic delay.
Low Expression Levels of Survivin89-142 and SurvivinC84A Do Not Explain Their Inability to Restore the Spindle Checkpoint Defect
The inability of Survivin89-142 and SurvivinC84A to restore the spindle checkpoint defect of Survivin-depleted cells could be explained by low expression levels of these proteins. In other words, low levels of Survivin might be sufficient to rescue cytokinesis, whereas higher levels of Survivin might be required to sustain the spindle checkpoint. To investigate this possibility, we cotransfected U2OS cells with Survivin siRNA and different concentrations of the Survivin1-142 expression plasmid. If indeed higher Survivin levels are needed to rescue the spindle checkpoint defect than the cytokinesis defect, it is expected that at a certain level of Survivin1-142 this difference becomes apparent. Titration of Survivin1-142 resulted in a concomitant decrease in rescue potential of the cytokinesis (Figure 2B) and spindle checkpoint defect (Figure 2C). The lowest concentration of Survivin1-142 that rescued the cytokinesis failure to a comparable level as the Survivin89-142 and SurvivinC84A mutants was 0.1 µg (Figure 2B). Yet, at this concentration, Survivin1-142 still significantly restored spindle checkpoint function (Figure 2C). We were unable to find a concentration at which Survivin1-142 mimics the differential rescue effect of Survivin89-142 and SurvivinC84A. These findings therefore suggest that the differential rescue capacity of Survivin89-142 and SurvivinC84A is not because of reduced expression levels but because of a functionally different behavior: the C-terminal
-helical coiled coil of Survivin is necessary and sufficient to restore the cytokinesis defect of Survivin-depleted cells, but the additional presence of a functional BIR domain is necessary to restore the spindle checkpoint defect.
|
|
Localization of the other mutant proteins correlated very well with their functional behavior. In line with its lack of rescue activity, Survivin1-89 did not localize to the centromeres or to the midzone but was found dispersed throughout the cytoplasm (Figure 3Ab' + b'', VSV columns, and B). In line with this, Survivin1-89 also completely failed to relocalize Aurora B to centromeres and central spindle (Figure 3Ab' + b'', Aurora B column, and C). Interestingly, Survivin89-142 and SurvivinC84A, incapable of rescuing the spindle checkpoint defect but capable of rescuing the cytokinesis failure, were hardly detectable on centromeres but clearly detectable on midzone and midbody (Figure 3Ac' + c'', e' + e'', VSV column, and B, and Supplemental Figure 1). In 13% of Survivin89-142 and 21% of the SurvivinC84A-reconstituted cells, we could detect these mutants on the centromeres but always at very low levels (Figures 3B and 6Bd'), implying that these mutants are able to interact with centromeres but that they have a severely reduced affinity for this chromosome structure. Importantly, in Survivin89-142 and SurvivinC84A-reconstituted cells, Aurora B colocalized with these mutant proteins on the midzone and midbody, but it was hardly detectable on the centromeres (Figure 3Ac' + c'', e' + e'', Aurora B column, and C). In line with the reduced centromeric localization of Aurora B in the Survivin1-89, Survivin89-142, and SurvivinC84A-reconstituted cells phosphorylation of the Aurora B substrate, CENP-A was also severely impaired in these cells (Supplemental Figure 2, A and B) (Zeitlin et al., 2001
; Lampson and Kapoor, 2005
).
|
|
|
Importantly, in 24% of the Survivin89-142-reconstituted and 56% of the SurvivinC84A-complemented cells we found that chromosome alignment was normal (Table 1 and Figure 4B). Because Aurora B is important for the establishment of bipolar attachments of the microtubules from the mitotic spindle to the sister chromatids (Tanaka et al., 2002
; Lampson et al., 2004
), the most likely explanation for this result is that low levels of Aurora B protein and kinase activity at the centromeres, as occasionally observed in the Survivin89-142 and SurvivinC84A-expressing cells (Figure 3C and Supplemental Figure 2, A and B), are sufficient for correcting maloriented microtubules in an unperturbed mitosis but may fail to do so when normal spindle formation is perturbed by drugs. These data thus imply that higher levels of Survivin and Aurora B are needed at the centromere to sustain a mitotic delay after paclitaxel treatment than to resolve occasional maloriented kinetochoremicrotubule attachments in an unperturbed mitosis.
Survivin89-142 and SurvivinC84A Are Unable to Retain High Levels of BubR1 at Kinetochores
To further understand why Survivin knockdown cells complemented with Survivin89-142 and SurvivinC84A are unable to restore a mitotic arrest after paclitaxel treatment, we checked kinetochore localization of BubR1. As shown previously, kinetochore localization of BubR1 is greatly reduced in cells lacking Survivin, even when treated with paclitaxel (Carvalho et al., 2003
; Lens et al., 2003
) (Figure 5A). Importantly, the proteins that could rescue the spindle checkpoint override (Survivin1-142 and SurvivinT34A) were also able to localize BubR1 to the kinetochores (Figure 5Ba,d and C). In contrast, for the mutants that failed to restore a paclitaxel-induced mitotic delay (e.g., Survivin1-89, Survivin89-142, and SurvivinC84A) we found that the BubR1 intensity levels at the majority of kinetochores were very low (<0.8 over background) (Figure 5Bb,c,e and C). Thus, the inability of the latter mutants to maintain high levels of BubR1 at the kinetochores correlates very well with their incapacity to restore the spindle checkpoint defect in Survivin-depleted cells.
|
| DISCUSSION |
|---|
|
|
|---|
SurvivinC84A has been described to act as a dominant negative protein that could induce apoptosis and cell division defects by displacing wild-type, endogenous Survivin from polymerized microtubules (Li et al., 1998
, 1999
). Similar to Skoufias et al. (2000
), mere overexpression of SurvivinC84A in U2OS cells did not result in any cell division defects in our hands (Lens and Rodriguez, unpublished data). More importantly, when localization of this mutant was monitored in the presence of endogenous Survivin, it was found to localize diffusely throughout the mitotic cell. The typical midzone and midbody localization of SurvivinC84A became only apparent when expression of endogenous Survivin was suppressed by siRNA (Lens, unpublished observation). Its incapacity to displace endogenous Survivin from centromeres and the central spindle may explain why this typical localization pattern of SurvivinC84A was missed previously (Skoufias et al., 2000
) and why in our hands overexpression of this mutant does not have any dominant negative effects. However, by combining mutational analysis with RNAi complementation, we have revealed a novel function for the BIR domain; it is essential for centromere localization and spindle checkpoint function of Survivin.
Overexpression experiments with SurvivinT34A suggested that also this mutant could act in a dominant negative manner (O'Connor et al., 2000
; Grossman et al., 2001
). The fact that this mutant can localize to all the expected sites during cell division, even in the presence of endogenous Survivin (Lens, unpublished observation), suggests that SurvivinT34A is able to compete with the localization of endogenous Survivin and that in principle it could act as a dominant negative protein. Yet, overexpression of this mutant did not affect the cell cycle or cell survival (Lens and Rodriguez, unpublished data). More importantly, this mutant was as effective as the wild-type protein in restoring all the cell cycle defects induced by Survivin depletion, indicating that CDK-dependent phosphorylation of T34 is not essential for Survivin function during mitosis.
Survivin-depleted cells are unable to sustain a mitotic delay induced by treatment with paclitaxel (Carvalho et al., 2003
; Lens et al., 2003
). The Survivin89-142 and SurvivinC84A mutants, although capable of restoring cytokinesis, could not restore this mitotic delay in Survivin-depleted cells most likely because these mutants did not fully reestablish Aurora B and BubR1 localization at the centromeres and kinetochores, respectively. Aurora B is thought to influence spindle checkpoint activity by destabilizing kinetochoremicrotubule attachments that do not create tension (e.g., that are nonbipolar) (Biggins and Murray, 2001
; Tanaka et al., 2002
; Lampson et al., 2004
). The resulting unattached kinetochore most likely (re)recruits Mad2 that will inhibit the APC/C (Zhou et al., 2002
; Lens and Medema, 2003
). In addition, sustained kinetochore localization of BubR1 seems to be Survivin/Aurora B-dependent (Carvalho et al., 2003
; Ditchfield et al., 2003
; Lens et al., 2003
). Interestingly, when mitotic progression was studied in the absence of paclitaxel, in 38% of the Survivin89-142- and 33% of the SurvivinC84A-reconstituted cells chromosome congression was impaired. Still, in 24% of the Survivin89-142- and 56% of the SurvivinC84A-reconstituted cells chromosome alignment was apparently normal. This could mean that the low protein levels and kinase activity of centromeric Aurora B that we sometimes observed in Survivin89-142- and SurvivinC84A-reconstituted cells is sufficient to reorientate an occasional misattached microtubule in an unperturbed mitosis but is not sufficient to sustain a mitotic delay after microtubule stabilization induced by paclitaxel. Moreover, the inability of the Survivin89-142 and SurvivinC84A mutants to restore normal levels of BubR1 at the kinetochores may also contribute to their incapacity to restore a paclitaxel-induced mitotic delay. Interestingly, these data also suggest that a gradual reduction of the levels of the CPC at the centromeres results in a gradual loss of checkpoint functionality, and as such (minor) changes in the level of CPC components could potentially lead to mild checkpoint defects.
By combining mutational analysis and siRNA complementation, we were able to uncouple Survivin's centromere localization and spindle checkpoint function from its central spindle localization and cytokinesis function. Interestingly, in Drosophila secondary spermatocytes, cytokinesis can take place in the absence of chromosomes and importantly, Aurora B was found to be normally localized at the midzone (Bucciarelli et al., 2003
). This is in line with our findings and suggests that centromeric concentration of the CPC is not a prerequisite for its accumulation at the central spindle. Similarly, overexpression of an N-terminal fragment of Borealin (aa 1-141) in Borealin-proficient cells displaced the other passenger proteins from the centromeres but did not affect their midbody localization (Gassmann et al., 2004
). Interestingly, when this N-terminal Borealin fragment was expressed in Borealin-depleted cells, it was also able to localize to the central spindle, but not to the centromeres. Thus, the Borealin N terminus seems to localize in a similar manner in Borealin-depleted cells as the Survivin C terminus in Survivin-depleted cells. Nonetheless, the Borealin N terminus could not efficiently rescue the cytokinesis defect of Borealin-depleted cells. Whereas full-length Borealin can directly interact with INCENP, the Borealin N-terminal fragment cannot (Gassmann et al., 2004
). Moreover, we found Borealin/Dasra B to be important for an efficient interaction between Survivin and INCENP, and Survivin to be capable of localizing the CPC in the absence of Borealin/Dasra B when directly fused to INCENP (Vader et al., 2006
). Thus, in Survivin-depleted cells reconstituted with Survivin89-142, endogenous full-length Borealin/Dasra B will be able to interact with both the Survivin mutant as well as with INCENP/Aurora B. In contrast, in Borealin-depleted cells reconstituted with Borealin1-141, Borealin/Dasra B may be able to interact with endogenous Survivin but cannot make the connection with INCENP/Aurora B. Together with Survivin, this Borealin mutant could therefore localize to the central spindle but is most likely unable to relocalize the other passengers to this structure, hence its incapacity to functionally complement the cytokinesis defect.
With respect to the centromere localization, we propose that the Survivin BIR domain is the portion of the CPC that interacts with the centromere. A single point mutation in the BIR domain of Survivin is sufficient to disturb its centromere localization but does not abolish its interaction with Borealin/Dasra B. Thus, unlike BIR-1 in C. elegans (Romano et al., 2003
), the BIR domain of mammalian Survivin is not essential for Borealin/Dasra B interaction. Again, Borealin/Dasra B may help in connecting centromere-bound Survivin to INCENP and Aurora B, and the entire complex may subsequently stabilize the Survivincentromere interaction. By binding to Survivin but failing to make the connection with INCENP and Aurora B, Borealin1-141 may thus prevent stabilization of the Survivincentromere interaction.
Our combined findings imply that Survivin is crucial for the spatial control of the chromosomal passenger complex. By interfering with its localization during mitosis, typical CPC-associated functions, such as sustaining a mitotic arrest in the absence of bipolar spindle attachments and execution of cytokinesis, can be uncoupled. Further understanding on how the different domains within Survivin are able to dictate its localization will provide insight into the spatiotemporal regulation of the CPC and its role in maintaining a stable genome.
| ACKNOWLEDGMENTS |
|---|
|
|
|---|
| Footnotes |
|---|
Abbreviations used: BIR, baculovirus IAP repeat; CPC, chromosomal passenger complex.
The online version of this article contains supplemental material at MBC Online (http://www.molbiolcell.org). ![]()
Address correspondence to: Susanne M.A. Lens (s.m.a.lens{at}med.uu.nl).
| REFERENCES |
|---|
|
|
|---|
Ambrosini, G., Adida, C., and Altieri, D. C. ((1997). ). A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 3, , 917-921.[CrossRef][Medline]
Biggins, S., and Murray, A. W. ((2001). ). The budding yeast protein kinase Ipl1/Aurora allows the absence of tension to activate the spindle checkpoint. Genes Dev. 15, , 3118-3129.
Bischoff, J. R., et al. ((1998). ). A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. 17, , 3052-3065.[CrossRef][Medline]
Brummelkamp, T. R., Bernards, R., and Agami, R. ((2002). ). A system for stable expression of short interfering RNAs in mammalian cells. Science 296, , 550-553.
Bucciarelli, E., Giansanti, M. G., Bonaccorsi, S., and Gatti, M. ((2003). ). Spindle assembly and cytokinesis in the absence of chromosomes during Drosophila male meiosis. J. Cell Biol. 160, , 993-999.
Carvalho, A., Carmena, M., Sambade, C., Earnshaw, W. C., and Wheatley, S. P. ((2003). ). Survivin is required for stable checkpoint activation in taxol-treated HeLa cells. J. Cell Sci. 116, , 2987-2998.
Chantalat, L., Skoufias, D. A., Kleman, J. P., Jung, B., Dideberg, O., and Margolis, R. L. ((2000). ). Crystal structure of human survivin reveals a bow tie-shaped dimer with two unusual alpha-helical extensions. Mol. Cell 6, , 183-189.[CrossRef][Medline]
Cooke, C. A., Heck, M. M., and Earnshaw, W. C. ((1987). ). The inner centromere protein (INCENP) antigens: movement from inner centromere to midbody during mitosis. J. Cell Biol. 105, , 2053-2067.
Ditchfield, C., Johnson, V. L., Tighe, A., Ellston, R., Haworth, C., Johnson, T., Mortlock, A., Keen, N., and Taylor, S. S. ((2003). ). Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores. J. Cell Biol. 161, , 267-280.
Fraser, A. G., James, C., Evan, G. I., and Hengartner, M. O. ((1999). ). Caenorhabditis elegans inhibitor of apoptosis protein (IAP) homologue BIR-1 plays a conserved role in cytokinesis. Curr. Biol. 9, , 292-301.[CrossRef][Medline]
Gassmann, R., Carvalho, A., Henzing, A. J., Ruchaud, S., Hudson, D. F., Honda, R., Nigg, E. A., Gerloff, D. L., and Earnshaw, W. C. ((2004). ). Borealin: a novel chromosomal passenger required for stability of the bipolar mitotic spindle. J. Cell Biol. 166, , 179-191.
Grossman, D., Kim, P. J., Schechner, J. S., and Altieri, D. C. ((2001). ). Inhibition of melanoma tumor growth in vivo by survivin targeting. Proc. Natl. Acad. Sci. USA 98, , 635-640.
Hauf, S., Cole, R. W., LaTerra, S., Zimmer, C., Schnapp, G., Walter, R., Heckel, A., van Meel, J., Rieder, C. L., and Peters, J. M. ((2003). ). The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint. J. Cell Biol. 161, , 281-294.
Honda, R., Korner, R., and Nigg, E. A. ((2003). ). Exploring the functional interactions between Aurora B, INCENP, and survivin in mitosis. Mol. Biol. Cell 14, , 3325-3341.
Hoyt, M. A., Totis, L., and Roberts, B. T. ((1991). ). S. cerevisiae genes required for cell cycle arrest in response to loss of microtubule function. Cell 66, , 507-517.[CrossRef][Medline]
Hwang, L. H., Lau, L. F., Smith, D. L., Mistrot, C. A., Hardwick, K. G., Hwang, E. S., Amon, A., and Murray, A. W. ((1998). ). Budding yeast Cdc 20, a target of the spindle checkpoint. Science 279, , 1041-1044.
Kalejta, R. F., Shenk, T., and Beavis, A. J. ((1997). ). Use of a membrane-localized green fluorescent protein allows simultaneous identification of transfected cells and cell cycle analysis by flow cytometry. Cytometry 29, , 286-291.[CrossRef][Medline]
Kanda, T., Sullivan, K. F., and Wahl, G. M. ((1998). ). Histone-GFP fusion protein enables sensitive analysis of chromosome dynamics in living mammalian cells. Curr. Biol. 8, , 377-385.[CrossRef][Medline]
Kim, S. H., Lin, D. P., Matsumoto, S., Kitazono, A., and Matsumoto, T. ((1998). ). Fission yeast Slp 1, an effector of the Mad2-dependent spindle checkpoint. Science 279, , 1045-1047.
Lampson, M. A., and Kapoor, T. M. ((2005). ). The human mitotic checkpoint protein BubR1 regulates chromosome-spindle attachments. Nat. Cell Biol. 7, , 93-98.[CrossRef][Medline]
Lampson, M. A., Renduchitala, K., Khodjakov, A., and Kapoor, T. M. ((2004). ). Correcting improper chromosome-spindle attachments during cell division. Nat. Cell Biol.
Lens, S. M., and Medema, R. H. ((2003). ). The survivin/Aurora B complex: its role in coordinating tension and attachment. Cell Cycle 2, , 507-510.[Medline]
Lens, S. M., Wolthuis, R. M., Klompmaker, R., Kauw, J., Agami, R., Brummelkamp, T., Kops, G., and Medema, R. H. ((2003). ). Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension. EMBO J. 22, , 2934-2947.[CrossRef][Medline]
Li, F., Ackermann, E. J., Bennett, C. F., Rothermel, A. L., Plescia, J., Tognin, S., Villa, A., Marchisio, P. C., and Altieri, D. C. ((1999). ). Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat. Cell Biol. 1, , 461-466.[CrossRef][Medline]
Li, F., Ambrosini, G., Chu, E. Y., Plescia, J., Tognin, S., Marchisio, P. C., and Altieri, D. C. ((1998). ). Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396, , 580-584.[CrossRef][Medline]
Li, F., Flanary, P. L., Altieri, D. C., and Dohlman, H. G. ((2000). ). Cell division regulation by BIR1, a member of the inhibitor of apoptosis family in yeast. J. Biol. Chem. 275, , 6707-6711.
Li, R., and Murray, A. W. ((1991). ). Feedback control of mitosis in budding yeast. Cell 66, , 519-531.[CrossRef][Medline]
Li, Y., and Benezra, R. ((1996). ). Identification of a human mitotic checkpoint gene: hsMAD2. Science 274, , 246-248.
Muchmore, S. W., Chen, J., Jakob, C., Zakula, D., Matayoshi, E. D., Wu, W., Zhang, H., Li, F., Ng, S. C., and Altieri, D. C. ((2000). ). Crystal structure and mutagenic analysis of the inhibitor-of-apoptosis protein survivin. Mol. Cell 6, , 173-182.[CrossRef][Medline]
Musacchio, A., and Hardwick, K. G. ((2002). ). The spindle checkpoint: structural insights into dynamic signalling. Nat. Rev. Mol. Cell. Biol. 3, , 731-741.[CrossRef][Medline]
O'Connor, D. S., Grossman, D., Plescia, J., Li, F., Zhang, H., Villa, A., Tognin, S., Marchisio, P. C., and Altieri, D. C. ((2000). ). Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc. Natl. Acad. Sci. USA 97, , 13103-13107.
Pines, J. ((1997). ). Localization of cell cycle regulators by immunofluorescence. Methods Enzymol. 283, , 99-113.[Medline]
Rajagopalan, H., and Lengauer, C. ((2004). ). Aneuploidy and cancer. Nature 432, , 338-341.[CrossRef][Medline]
Rieder, C. L., Cole, R. W., Khodjakov, A., and Sluder, G. ((1995). ). The checkpoint delaying anaphase in response to chromosome monoorientation is mediated by an inhibitory signal produced by unattached kinetochores. J. Cell Biol. 130, , 941-948.
Romano, A., Guse, A., Krascenicova, I., Schnabel, H., Schnabel, R., and Glotzer, M. ((2003). ). CSC-1, a subunit of the Aurora B kinase complex that binds to the survivin-like protein BIR-1 and the incenp-like protein ICP-1. J. Cell Biol. 161, , 229-236.
Sampath, S. C., Ohi, R., Leismann, O., Salic, A., Pozniakovski, A., and Funabiki, H. ((2004). ). The chromosomal passenger complex is required for chromatin-induced microtubule stabilization and spindle assembly. Cell 118, , 187-202.[CrossRef][Medline]
Shah, J. V., and Cleveland, D. W. ((2000). ). Waiting for anaphase: Mad2 and the spindle assembly checkpoint. Cell 103, , 997-1000.[CrossRef][Medline]
Skoufias, D. A., Mollinari, C., Lacroix, F. B., and Margolis, R. L. ((2000). ). Human survivin is a kinetochore-associated passenger protein. J. Cell Biol. 151, , 1575-1582.
Smits, V. A., Klompmaker, R., Arnaud, L., Rijksen, G., Nigg, E. A., and Medema, R. H. ((2000). ). Polo-like kinase-1 is a target of the DNA damage checkpoint. Nat. Cell Biol. 2, , 672-676.[CrossRef][Medline]
Speliotes, E. K., Uren, A., Vaux, D., and Horvitz, H. R. ((2000). ). The survivin-like C. elegans BIR-1 protein acts with the Aurora-like kinase AIR-2 to affect chromosomes and the spindle midzone. Mol. Cell 6, , 211-223.[CrossRef][Medline]
Storchova, Z., and Pellman, D. ((2004). ). From polyploidy to aneuploidy, genome instability and cancer. Nat. Rev. Mol. Cell. Biol. 5, , 45-54.[CrossRef][Medline]
Sudakin, V., Chan, G. K., and Yen, T. J. ((2001). ). Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2. J. Cell Biol. 154, , 925-936.
Tanaka, T. U., Rachidi, N., Janke, C., Pereira, G., Galova, M., Schiebel, E., Stark, M. J., and Nasmyth, K. ((2002). ). Evidence that the Ipl1-Sli15 (Aurora kinase-INCENP) complex promotes chromosome bi-orientation by altering kinetochore-spindle pole connections. Cell 108, , 317-329.[CrossRef][Medline]
Tang, Z., Bharadwaj, R., Li, B., and Yu, H. ((2001). ). Mad2-Independent inhibition of APCCdc20 by the mitotic checkpoint protein BubR1. Dev. Cell 1, , 227-237.[CrossRef][Medline]
Taylor, S. S., Ha, E., and McKeon, F. ((1998). ). The human homologue of Bub3 is required for kinetochore localization of Bub1 and a Mad3/Bub1-related protein kinase. J. Cell Biol. 142, , 1-11.
Taylor, S. S., Hussein, D., Wang, Y., Elderkin, S., and Morrow, C. J. ((2001). ). Kinetochore localisation and phosphorylation of the mitotic checkpoint components Bub1 and BubR1 are differentially regulated by spindle events in human cells. J. Cell Sci. 114, , 4385-4395.[Medline]
Vader, G., Kauw, J. J., Medema, R. H., and Lens, S. M. ((2006). ). Survivin mediates targeting of the chromosomal passenger complex to the centromere and midbody. EMBO Rep. 7, , 85-92.[CrossRef][Medline]
Vagnarelli, P., and Earnshaw, W. C. ((2004). ). Chromosomal passengers: the four-dimensional regulation of mitotic events. Chromosoma 113, , 211-222.[CrossRef][Medline]
Verdecia, M. A., Huang, H., Dutil, E., Kaiser, D. A., Hunter, T., and Noel, J. P. ((2000). ). Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement. Nat. Struct. Biol. 7, , 602-608.[CrossRef][Medline]
Zeitlin, S. G., Shelby, R. D., and Sullivan, K. F. ((2001). ). CENP-A is phosphorylated by Aurora B kinase and plays an unexpected role in completion of cytokinesis. J. Cell Biol. 155, , 1147-1157.
Zhou, J., Yao, J., and Joshi, H. C. ((2002). ). Attachment and tension in the spindle assembly checkpoint. J. Cell Sci. 115, , 3547-3555.
This article has been cited by other articles:
![]() |
Y. Jiang, W. Nishimura, D. Devor-Henneman, D. Kusewitt, H. Wang, M. P. Holloway, T. Dohi, E. Sabo, M. L. Robinson, D. C. Altieri, et al. Postnatal Expansion of the Pancreatic {beta}-Cell Mass Is Dependent on Survivin Diabetes, October 1, 2008; 57(10): 2718 - 2727. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gao, M. G. Giansanti, G. J. Buttrick, S. Ramasubramanyan, A. Auton, M. Gatti, and J. G. Wakefield Australin: a chromosomal passenger protein required specifically for Drosophila melanogaster male meiosis J. Cell Biol., February 6, 2008; 180(3): 521 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bourhis, S. G. Hymowitz, and A. G. Cochran The Mitotic Regulator Survivin Binds as a Monomer to Its Functional Interactor Borealin J. Biol. Chem., November 30, 2007; 282(48): 35018 - 35023. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Vader, C. W.A. Cruijsen, T. van Harn, M. J.M. Vromans, R. H. Medema, and S. M.A. Lens The Chromosomal Passenger Complex Controls Spindle Checkpoint Function Independent from Its Role in Correcting Microtubule Kinetochore Interactions Mol. Biol. Cell, November 1, 2007; 18(11): 4553 - 4564. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Vader, R. H. Medema, and S. M.A. Lens The chromosomal passenger complex: guiding Aurora-B through mitosis J. Cell Biol., June 19, 2006; 173(6): 833 - 837. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. R. Klein, E. A. Nigg, and U. Gruneberg Centromere Targeting of the Chromosomal Passenger Complex Requires a Ternary Subcomplex of Borealin, Survivin, and the N-Terminal Domain of INCENP Mol. Biol. Cell, June 1, 2006; 17(6): 2547 - 2558. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||